The Notice on Further Strengthening the Administration of ephedrine-containing Compound Preparations was issued on Oct.27, 2008. It aims to further strengthen the management of ephedrine-containing compound preparations (excluding ephedrine-containing proprietary Chinese medicines) and ensure the public demand for drugs, which includes relevant policies, regulations, and measures to ensure compliance, safety, and transparency of products and promotions in these areas.